Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Cancer Genetics (CGIX) at the Forefront of Personalized Medicine

Cancer Genetics, Inc. (NASDAQ: CGIX) is focused on the development of personalized genetic testing for the detection of various cancers, with the goal of significantly increasing treatment efficacy while reducing healthcare costs. CGI’s scientific advisory board includes leaders in the areas of hematological malignancies, solid tumor cancers, pharmacogenomics, and clinical trials administration. The company’s growing […]

The Clorox Company (CLX): A True Global Conglomerate with Community Values

The Clorox Company (NYSE: CLX) manufactures and markets consumer and professional products worldwide. The company operates through four segments: Cleaning, Household, Lifestyle, and International. Clorox is a global company with leading brands that have become household names, including its namesake bleach and cleaning products; Green Works naturally derived cleaning products; Ayudín and Poett home care […]

Nike, Inc. (NKE) Continues Worldwide Growth

Nike, Inc. (NYSE: NKE), headquartered in Beaverton, OR, is the world’s leading sportswear and sporting goods company, with a market cap approaching $100 billion. Founded in 1964 as Blue Ribbon Sports, and changing its name to NIKE in 1971, the company offers a full range of sports related clothing, accessories, and equipment through sports and […]

Stellar Biotechnologies, Inc. (SBOT) Announces Joint Venture With Neovacs S.A.

Stellar Biotechnologies, Inc. (NASDAQ: SBOT), a California-based biotechnology company and world leader in the sustainable manufacture of keyhole limpet hemocyanin (KLH), a protein used for stimulating and measuring immune response, has announced plans to form a joint venture with Neovacs S.A., a French biotechnology company focused on an active immunotherapy technology platform. The joint venture […]

View Systems, Inc. (VSYM) Enters into Definitive Agreement to Acquire Y.M. Advantage, Inc.

Earlier today, View Systems, Inc. (OTC: VSYM), a manufacturer and installer of non-invasive weapons detection systems for government and commercial use, announced it has entered into a definitive agreement to acquire Y.M. Advantage, Inc. (YMA), a private corporation engaged in the acquisition, development and management of medical clinics providing treatment for various medical issues. Through […]

Avant Diagnostics (AVDX): Trials and Tribulations

Recently, in Avant Diagnostics set to exploit new opportunities in the laboratory testing market (http://dtn.fm/hg8TK), we reported that ‘OvaDx is now undergoing 510K trials.’ It seems we jumped the gun. We reached out to Avant’s CEO, Gregg Linn, to get clarification on our report and he confirmed that the OvaDx approval process hasn’t reached the […]

Avant Diagnostics, Inc. (AVDX) Ovarian Cancer Early Detection Diagnostic Tech Bolstered Mightily By Amarantus Bioscience Merger

According to recent analysis out late last year from the world’s second largest publisher of premium market reports, MarketsandMarkets, the global market for biomarkers is on-track to grow at a CAGR of 13.58 percent through 2020, reaching upwards of $45.55 billion on the strength of increasing healthcare, as well as R&D spending. A key driver […]

 

From Our Blog

Beeline Holdings, Inc. (NASDAQ: BLNE) CEO Details 2025 Milestones and Strategic Priorities

January 20, 2026

Beeline Holdings (NASDAQ: BLNE),  a rapidly growing digital mortgage platform streamlining the path to homeownership, presented a series of operational and financial milestones from 2025 while setting out the company’s strategic priorities for the year ahead, according to a shareholder letter published by CEO Nick Liuzza on January 15, 2026. The letter provides investors with […]

Rotate your device 90° to view site.